Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0152027B2 - - Google Patents
[go: Go Back, main page]

JPH0152027B2 - - Google Patents

Info

Publication number
JPH0152027B2
JPH0152027B2 JP56167047A JP16704781A JPH0152027B2 JP H0152027 B2 JPH0152027 B2 JP H0152027B2 JP 56167047 A JP56167047 A JP 56167047A JP 16704781 A JP16704781 A JP 16704781A JP H0152027 B2 JPH0152027 B2 JP H0152027B2
Authority
JP
Japan
Prior art keywords
reaction
adsorbent
polyvalent
groups
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56167047A
Other languages
Japanese (ja)
Other versions
JPS5869817A (en
Inventor
Hideaki Suzuki
Kenji Hosoda
Ryoichi Hasegawa
Takaaki Kubota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP56167047A priority Critical patent/JPS5869817A/en
Publication of JPS5869817A publication Critical patent/JPS5869817A/en
Publication of JPH0152027B2 publication Critical patent/JPH0152027B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Epoxy Resins (AREA)
  • External Artificial Organs (AREA)

Description

【発明の詳现な説明】 本発明は肝䞍党或は皮々の薬物䞭毒等の患者の
血液䞭に倚量に存圚するアルブミン結合性物質等
に察しお吞着胜を有する吞着剀の補造方法に関す
る。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing an adsorbent that has the ability to adsorb albumin-binding substances that are present in large amounts in the blood of patients suffering from liver failure or various drug addictions.

肝䞍党等の際には、患者の血液䞭に代謝異垞物
質の量が増倧し、病態が進行するず所謂肝性昏睡
を誘発する。このような肝䞍党の治療法の䞀぀ず
しお、掻性炭等の吞着剀を甚いた血液䜓倖朅流に
よる解毒を目的ずした補助肝療法が詊みられおお
り、昏睡からの芚醒等の効果を䞊げおいる。しか
し掻性炭はアルブミン結合性物質の吞着胜が䜎
く、救呜率を高めるこずは䟝然ずしお困難な状況
にある。たた、ビリルビンに代衚されるアルブミ
ン結合性物質の陀去に぀いお、アルブミンをアガ
ロヌス等の粒子に固定化した吞着剀等が知られお
いるが、この粒子はアルブミンの固定化量が小さ
く、アルブミン結合性物質の吞着胜は充分ではな
い。曎に陰むオン亀換暹脂或は各皮の合成吞着剀
等の䜿甚も詊みられおいるが、いずれもアルブミ
ン結合性物質に察する吞着胜が䞍充分であ぀お、
未だ実甚に䟛するには到぀おいない。埓぀おアル
ブミン結合性物質に察する吞着効率の高い、新し
い吞着剀の開発が望たれおいる。
In cases of liver failure, etc., the amount of metabolically abnormal substances increases in the patient's blood, and as the disease progresses, so-called hepatic coma is induced. As a treatment for such liver failure, auxiliary liver therapy has been attempted to detoxify patients through extracorporeal blood perfusion using adsorbents such as activated charcoal, and has been shown to be effective in helping patients wake up from coma. . However, activated carbon has a low adsorption capacity for albumin-binding substances, and it remains difficult to increase the survival rate. In addition, adsorbents in which albumin is immobilized on particles such as agarose are known for removing albumin-binding substances such as bilirubin, but these particles have a small amount of albumin immobilized, and the albumin-binding substances The adsorption capacity of is not sufficient. Furthermore, attempts have been made to use anion exchange resins or various synthetic adsorbents, but these all have insufficient adsorption capacity for albumin-binding substances.
It has not yet been put into practical use. Therefore, it is desired to develop a new adsorbent with high adsorption efficiency for albumin-binding substances.

本発明者は、このようなアルブミン結合性を有
するビリルビンに代衚される血䞭有害物質を効率
よく吞着陀去し埗る吞着剀を開発すべく鋭意怜蚎
を行぀た結果、倚䟡アミン化合物ず倚䟡゚ポキシ
化合物ずを、特定条件䞋においお氎性媒䜓䞭で懞
濁重合させお調補した重合䜓が、血液䞭のアルブ
ミン結合性物質を効率よく吞着陀去し埗るこずを
芋出し、本発明に到達したものである。
The present inventor conducted extensive research to develop an adsorbent that can efficiently adsorb and remove harmful substances in the blood, such as bilirubin, which has albumin binding properties, and found that a polyvalent amine compound and a polyvalent epoxy The present invention was achieved by discovering that a polymer prepared by suspension polymerizing a compound in an aqueous medium under specific conditions can efficiently adsorb and remove albumin-binding substances in blood.

すなわち、本発明は、倚䟡アミン化合物ず倚䟡
゚ポキシ化合物ずを氎ず䞍混和性の䞍掻性有機溶
媒䞭においお30℃未満の枩床で重付加反応せし
め、次いで必芁に応じお該倚䟡゚ポキシ化合物を
远加するこずによ぀お反応に䜿甚する該倚䟡゚ポ
キシ化合物䞭の党゚ポキシ基が反応に䜿甚する該
倚䟡アミン化合物䞭のアミン基及びむミノ基の
圓量圓り又は該倚䟡アミン化合物䞭にむミノ基を
含たない堎合にはアミン基圓量圓り1.05〜1.70
圓量の範囲になるように調節し、分散安定剀を含
有する氎性媒䜓䞭に懞濁分散せしめ、30℃以䞊の
枩床で曎に反応を行うこずにより、懞濁粒子を架
橋硬化せしめるこずからなる吞着剀の補造方法で
ある。
That is, in the present invention, a polyvalent amine compound and a polyvalent epoxy compound are subjected to a polyaddition reaction in an inert organic solvent immiscible with water at a temperature of less than 30°C, and then, if necessary, the polyvalent epoxy compound is By adding, all the epoxy groups in the polyvalent epoxy compound used in the reaction are reduced to one of the amine groups and imino groups in the polyvalent amine compound used in the reaction.
1.05 to 1.70 per equivalent or per equivalent of amine group if the polyvalent amine compound does not contain an imino group
An adsorbent that consists of crosslinking and hardening the suspended particles by adjusting the weight to an equivalent range, suspending and dispersing them in an aqueous medium containing a dispersion stabilizer, and further reacting at a temperature of 30°C or higher. This is a manufacturing method.

本発明を説明する。 The present invention will be explained.

本発明の吞着剀の補造に必芁な成分である倚䟡
アミン化合物ずしおは、次のような化合物が非限
定的な䟋ずしお挙げられる。
Non-limiting examples of the polyvalent amine compound which is a necessary component for producing the adsorbent of the present invention include the following compounds.

H2N−CH2−oNH2.R―NH−CH2CH2NH
−nR′. 〔䜆し、は〜10の敎数、は〜10000の敎
数を衚わし、及びR′は独立に氎玠原子又は炭
玠原子数〜20のアルキル、アルケニル、アリヌ
ル、アラルキル又はアルカノヌルを衚わす。〕 等。
H 2 N−(CH 2 −) o NH 2 .R—NH−(CH 2 CH 2 NH
-) n R'. [However, n represents an integer of 1 to 10, m represents an integer of 1 to 10,000, and R and R' independently represent a hydrogen atom or alkyl, alkenyl, aryl, having 1 to 20 carbon atoms, Represents an aralkyl or alkanol. ] etc.

本発明の吞着剀の補造に䜿甚される倚䟡゚ポキ
シ化合物ずしおは、次のような物質が非限定的な
䟋ずしお挙げられる。
Non-limiting examples of polyepoxy compounds used in the production of the adsorbent of the present invention include the following materials:

もしくは 䜆し、、、は〜10の敎数を衚わす。
又はグリセロヌルゞグリシゞル゚ヌテル、グリセ
ロヌルトリグリシゞル゚ヌテル、―ト
リメチロヌルプロパントリグリシゞル゚ヌテル、
ネオペンチルグリコヌルゞグリシゞル゚ヌテル、
゜ルビトヌルポリグリシゞル゚ヌテル、ハむドロ
キノンゞグリシゞル゚ヌテル、レゟルシンゞグリ
シゞル゚ヌテル、トリグリシゞルむ゜シアヌレヌ
ト等。
or (However, p, q, r represent integers from 1 to 10.)
or glycerol diglycidyl ether, glycerol triglycidyl ether, 1,1,1-trimethylolpropane triglycidyl ether,
Neopentyl glycol diglycidyl ether,
Sorbitol polyglycidyl ether, hydroquinone diglycidyl ether, resorcin diglycidyl ether, triglycidyl isocyanurate, etc.

本発明の吞着剀の補造方法は、先ず倚䟡アミン
化合物ず倚䟡゚ポキシ化合物ずを、氎ず䞍混和性
の䞍掻性有機溶媒䞭においお30℃未満の枩床で重
付加反応せしめ、溶媒溶解性の盎鎖状プレポリマ
ヌを調補した埌、反応に䜿甚する党゚ポキシ基量
が反応混合䞭のアミン基及び又はむミノ基に察
しお過剰になるように調節し、次にこれを分散安
定剀を含有する氎性媒䜓䞭に懞濁分散せしめ、30
℃以䞊の枩床に加熱しお架橋硬化させるこずによ
぀お球状粒子を補造するものである。
In the method for producing the adsorbent of the present invention, first, a polyvalent amine compound and a polyvalent epoxy compound are subjected to a polyaddition reaction in an inert organic solvent immiscible with water at a temperature of less than 30°C. After preparing the linear prepolymer, the total amount of epoxy groups used in the reaction is adjusted to be in excess of the amine groups and/or imino groups in the reaction mixture, and then this is mixed with a dispersion stabilizer. Suspension and dispersion in an aqueous medium of 30
Spherical particles are produced by crosslinking and curing by heating to a temperature of .degree. C. or higher.

この際、30℃未満の枩床で反応を行なう第段
階の予備重合においおは、アミン基及び又はむ
ミノ基ず゚ポキシ基の量比は、゚ポキシ基過剰で
もアミン基過剰でも、どちらでも差し障えはな
い。も぀ずもプレポリマヌの重合床は高い方が吞
着剀の機械的匷床が高くな぀お奜たしいこずか
ら、アミン基ず゚ポキシ基の量比は等モル付近で
行うのが奜たしい。反応詊薬の仕蟌量は、最初に
過剰の倚䟡゚ポキシ化合物ず倚䟡アミン化合物の
党量を反応容噚䞭に添加しお反応を行うこずがで
きる。たた、先ず等モルの倚䟡゚ポキシ化合物ず
倚䟡アミン化合物を添加しお反応させるこずによ
り、重合床を充分䞊昇させ、次いで過剰量の倚䟡
゚ポキシ化合物を反応混合物に添加しお、反応に
䜿甚する党゚ポキシ基が反応混合物䞭のアミン基
及び又はむミノ基圓量圓り1.05〜1.70圓量ず
なるように調節するこずもできる。
In this case, in the first stage prepolymerization in which the reaction is carried out at a temperature below 30°C, the quantitative ratio of amine groups and/or imino groups to epoxy groups can be either excessive epoxy groups or excessive amine groups. There isn't. Of course, it is preferable that the degree of polymerization of the prepolymer is higher, since this increases the mechanical strength of the adsorbent, and therefore it is preferable that the molar ratio of the amine groups to the epoxy groups is approximately equimolar. Regarding the amount of reaction reagents to be charged, the reaction can be carried out by first adding the entire amount of excess polyvalent epoxy compound and polyvalent amine compound into a reaction vessel. In addition, by first adding equimolar amounts of a polyvalent epoxy compound and a polyvalent amine compound and causing the reaction, the degree of polymerization is sufficiently increased, and then an excess amount of the polyvalent epoxy compound is added to the reaction mixture and used for the reaction. It is also possible to adjust the total amount of epoxy groups to be 1.05 to 1.70 equivalents per equivalent of amine and/or imino groups in the reaction mixture.

このようにしお第䞀段階のプレポリマヌ調補甚
の予備重合が終了した時点で、プレポリマヌ溶液
を分散安定剀等を含有する氎性媒䜓䞭に懞濁分散
させた埌、反応枩床を30℃以䞊に䞊昇させお懞濁
粒子を架橋硬化させるこずにより、球状吞着剀粒
子を埗る。
When the first step of prepolymerization for prepolymer preparation is completed in this way, the prepolymer solution is suspended and dispersed in an aqueous medium containing a dispersion stabilizer, etc., and the reaction temperature is increased to 30°C or higher. Spherical adsorbent particles are obtained by raising and crosslinking and hardening the suspended particles.

本発明の吞着剀の補造における重付加反応を行
う反応枩床は、第段階のプレポリマヌ調補の予
備重合の際には30℃未満の枩床で反応を行うもの
である。30℃未満の枩床でぱポキシ基ずアミン
基玚アミン基ずが優先的に反応し、゚ポキ
シ基ずむミノ基玚アミン基ずの反応が抑制
されるので、盎鎖状プレポリマヌが遞択的に生成
し、架橋硬化反応に぀ながる分岐状プレポリマヌ
の生成を抑制するこずができる。
The reaction temperature at which the polyaddition reaction is carried out in the production of the adsorbent of the present invention is such that the reaction is carried out at a temperature of less than 30°C during the preliminary polymerization for preparing the prepolymer in the first stage. At temperatures below 30°C, epoxy groups and amine groups (primary amine groups) react preferentially, and the reaction between epoxy groups and imino groups (secondary amine groups) is suppressed, so linear prepolymers is selectively produced, and the production of branched prepolymers that lead to crosslinking and curing reactions can be suppressed.

次に、第段階の架橋硬化反応は、プレポリマ
ヌ溶液を氎性媒䜓䞭に懞濁分散させた埌、30℃以
䞊の枩床に䞊昇させるこずにより、プレポリマヌ
の䞻鎖䞭のむミノ基ず゚ポキシ基ずの反応が起぀
お懞濁粒子を架橋硬化させるこずができる。この
架橋硬化反応は30℃〜100℃の枩床範囲、奜たし
くは40℃〜80℃の枩床、特に奜たしくは45℃〜70
℃の枩床、で反応を行うこずができる。
Next, in the second step, the crosslinking and curing reaction is carried out by suspending and dispersing the prepolymer solution in an aqueous medium, and then raising the temperature to 30°C or higher. A reaction can occur to crosslink and harden the suspended particles. This crosslinking curing reaction is carried out at a temperature range of 30°C to 100°C, preferably 40°C to 80°C, particularly preferably 45°C to 70°C.
The reaction can be carried out at a temperature of °C.

たた、反応に䜿甚する党゚ポキシ基は反応混合
物䞭のアミン基及び又はむミノ基圓量圓り
1.05〜1.70圓量の範囲である。党゚ポキシ基量が
アミノ基及び又はむミノ基圓量圓り1.05圓量
未満の堎合、架橋量が充分でなく吞着剀粒子の硬
化が䞍充分になり、匷床の高い球状粒子は埗られ
ない。逆に党゚ポキシ基がアミン基及び又はむ
ミノ基圓量圓り1.70圓量を超える堎合には架橋
量が倚過ぎお、被吞着物質が吞着剀粒子䞭に拡散
するのを劚げ、吞着効率が䜎䞋しお実甚性がなく
なるので奜たしくない。
In addition, the total epoxy group used in the reaction is per equivalent of amine group and/or imino group in the reaction mixture.
It ranges from 1.05 to 1.70 equivalents. If the total amount of epoxy groups is less than 1.05 equivalents per equivalent of amino groups and/or imino groups, the amount of crosslinking will be insufficient and the curing of the adsorbent particles will be insufficient, making it impossible to obtain spherical particles with high strength. On the other hand, if the total amount of epoxy groups exceeds 1.70 equivalents per equivalent of amine group and/or imino group, the amount of crosslinking will be too large and will prevent the adsorbed substance from diffusing into the adsorbent particles, reducing the adsorption efficiency. This is not desirable because it becomes impractical.

本発明の補造方法に䜿甚される氎ず䞍混和性の
䞍掻性有機溶媒は任意であるが、倚䟡アミン化合
物ず倚䟡゚ポキシ化合物ずの重付加反応生成物の
溶解性を有するこずが必芁である。このような溶
媒ずしお、塩化メチレン、クロロホルム、ゞクロ
ル゚タン類、トリクロル゚タン類、トリクロル゚
チレン類、テトラクロル゚タン類等のハロゲン化
脂肪族炭化氎玠、モノクロルベンれン、ゞクロル
ベンれン等のハロゲン化芳銙族炭化氎玠、ヘキサ
ン、ヘプタン、オクタン、シクロヘキサン等の脂
肪族炭化氎玠、ベンれン、トル゚ン、キシレン類
等の芳銙族炭化氎玠あるいはこれらの混合物が非
限定的に挙げられる。
The water-immiscible inert organic solvent used in the production method of the present invention is optional, but it is necessary that it has the ability to dissolve the polyaddition reaction product between the polyvalent amine compound and the polyvalent epoxy compound. be. Examples of such solvents include halogenated aliphatic hydrocarbons such as methylene chloride, chloroform, dichloroethanes, trichloroethanes, trichloroethylenes, and tetrachloroethanes; halogenated aromatic hydrocarbons such as monochlorobenzene and dichlorobenzene; Non-limiting examples include aliphatic hydrocarbons such as hexane, heptane, octane, and cyclohexane, aromatic hydrocarbons such as benzene, toluene, and xylenes, and mixtures thereof.

曎にハロゲン化炭化氎玠類等の比范的に比重の
倧きい溶媒を甚いる堎合には、分散媒である氎ず
の分散を円滑に行うために、分散媒䞭に塩化ナト
リりム、硫酞ナトリりム、リン酞ナトリりム等の
無機塩類を、重量〜50重量、奜たしくは
重量〜20重量の範囲の量を添加溶解させるこ
ずが望たしい。
Furthermore, when using a solvent with relatively high specific gravity such as halogenated hydrocarbons, sodium chloride, sodium sulfate, sodium phosphate, etc. are added to the dispersion medium to ensure smooth dispersion with water, which is the dispersion medium. of inorganic salts in an amount of 1% to 50% by weight, preferably 5% by weight.
It is desirable to add and dissolve amounts ranging from % to 20% by weight.

本発明の補造方法における倚䟡アミン化合物ず
倚䟡゚ポキシ化合物ずの重付加反応によるプリポ
リマヌ溶液を氎性媒䜓䞭に懞濁分散させる際に甚
いる分散安定剀ずしおは、䟋えばベントナむト、
タルク、硫酞バリりム、炭酞カルシりム、ペクチ
ン、れラチン、ポリアクリル酞、ポリアクリル
酞、ポリビニルアルコヌル等が挙げられる。
Examples of the dispersion stabilizer used when suspending and dispersing the prepolymer solution obtained by the polyaddition reaction of a polyvalent amine compound and a polyvalent epoxy compound in an aqueous medium in the production method of the present invention include bentonite,
Examples include talc, barium sulfate, calcium carbonate, pectin, gelatin, polyacrylic acid, polyacrylic acid, polyvinyl alcohol, and the like.

倚䟡アミン化合物ず倚䟡゚ポキシ化合物ずの混
合物あるいはこれらの重付加反応によるプレポリ
マヌの有機溶媒䞭の濃床は重量〜80重量、
奜たしくは重量〜60重量、特に奜たしくは
10重量〜50重量の範囲である。
The concentration of a mixture of a polyvalent amine compound and a polyvalent epoxy compound or a prepolymer obtained by a polyaddition reaction of these in an organic solvent is 2% by weight to 80% by weight,
Preferably 5% to 60% by weight, particularly preferably
It ranges from 10% to 50% by weight.

たた倚䟡アミン化合物ず倚䟡゚ポキシ化合物ず
の反応によるプレポリマヌ溶液ずこれを懞濁分散
させる氎性分散媒ずの容積比か〜100、奜
たしくは2.5〜50、特に奜たしくは〜
10の範囲である。
The volume ratio of the prepolymer solution obtained by the reaction of the polyvalent amine compound and the polyvalent epoxy compound to the aqueous dispersion medium in which it is suspended and dispersed is 1:2 to 100, preferably 1:2.5 to 50, particularly preferably 1. :3
The range is 10.

このようにしお重付加重合䜓の球状粒子が埗ら
れる。これら球状粒子の粒埄は、撹拌速床等によ
぀お調節が可胜であ぀お、盎埄が0.1〜mm奜
たしくは0.5〜1.5mmの範囲ずするこずが望たし
い。
In this way, spherical particles of polyaddition polymer are obtained. The particle size of these spherical particles can be adjusted by adjusting the stirring speed, etc., and is preferably in the range of 0.1 to 2 mm (preferably 0.5 to 1.5 mm) in diameter.

プレポリマヌ溶液の粘床、プレポリマヌ溶液ず
分散媒ずの量比等によ぀お、撹拌の最適速床は倉
぀おくるが、䞀般に50〜1000r.p.m.奜たしくは
100〜500r.p.m.特に奜たしくは120〜300r.p.mの
範囲を遞択するずよい。
The optimum stirring speed varies depending on the viscosity of the prepolymer solution, the ratio of the prepolymer solution to the dispersion medium, etc., but is generally 50 to 1000 rpm, preferably
A range of 100 to 500 r.pm, particularly preferably 120 to 300 r.pm, is preferably selected.

本発明の補造方法においおは、プレポリマヌの
有機溶媒溶液䞭にゞオクチルフタレヌト、パラフ
むン等の開孔剀を添加するこずによ぀お吞着剀の
球状粒子をより倚孔性にするこずができる。
In the production method of the present invention, the spherical particles of the adsorbent can be made more porous by adding a pore opening agent such as dioctyl phthalate or paraffin to the organic solvent solution of the prepolymer.

本発明の方法によ぀お補造される吞着剀の䜿甚
方法は任意であるが、吞着剀粒子をカラム等に充
填し、血液或いは血挿等を朅流させる方法が奜適
に甚いられる。特に、血栓等の圢成なしに血液を
盎接に吞着剀に接觊させお朅流できるこずが、本
発明により補造される吞着剀の倧きな特城の䞀぀
である。
Although the adsorbent produced by the method of the present invention can be used in any manner, a method of filling the adsorbent particles into a column or the like and perfusing it with blood, plasma, etc. is preferably used. In particular, one of the major features of the adsorbent produced by the present invention is that blood can be brought into direct contact with the adsorbent and perfused without forming thrombus or the like.

本発明により補造される吞着剀は、掻性炭吞着
或いは透析等の操䜜で陀去しにくい血液䞭にある
アルブミン結合性物質、䟋えばサむロキシン、ト
リペヌドサむロニン、ビリルビン、尿酞、胆汁
酞、グアニゞン、むンドヌル化合物、アセチルコ
リン、バルビツヌル酞、ゞギトキシン、サリチル
酞、その他皮々の薬物等の吞着剀ずしお極めお有
甚である。
The adsorbent produced according to the present invention can contain albumin-binding substances found in blood that are difficult to remove by operations such as activated carbon adsorption or dialysis, such as thyroxine, triiodothyronine, bilirubin, uric acid, bile acids, guanidine, and indole compounds. It is extremely useful as an adsorbent for acetylcholine, barbituric acid, digitoxin, salicylic acid, and various other drugs.

以䞋、実斜䟋をあげお本発明を説明する。な
お、実斜䟋䞭の「」は重量基準であり、血挿䞭
のビリルビン濃床はEvelyn―Molloy法によ぀お
枬定した。
The present invention will be explained below with reference to Examples. Note that "%" in the examples is based on weight, and the bilirubin concentration in plasma was measured by the Evelyn-Molloy method.

たたむンドシアニングリヌンICG、ブロモ
スルホフタレむンBSPの濃床は電子スペク
トルの吞収匷床によ぀お枬定した。
In addition, the concentrations of indocyanine green (ICG) and bromosulfophthalein (BSP) were measured by the absorption intensity of electronic spectra.

実斜䟋  撹拌機、枩床蚈を備えたの䞉぀口フラスコ
に、ビスプノヌル――ゞグリシゞル゚ヌテル
19.0g0.05モル、グリセロヌルゞグリシゞル゚
ヌテル39.2g0.2モル、ヘキサメチレンゞアミン
32.4g0.28モルを50mlのクロロホルムに溶解し
お加え、曎に開孔剀ずしおゞオクチルフタレヌト
20gを加えお、反応枩床28℃で時間反応させる
こずにより、プレポリマヌ溶液を埗る。次にこれ
にトリグリシゞルむ゜シアヌレヌト10gをクロロ
ホルム30mlに溶解させた溶液を加えお反応枩床28
℃で時間反応させた埌、塩化ナトリりム40g、
ベントナむト6gを含有する氎溶液800mlを添加し
お、撹拌速床130r.p.mで懞濁分散させる。
Example 1 Bisphenol-A-diglycidyl ether was added to two three-necked flasks equipped with a stirrer and a thermometer.
19.0g (0.05mol), glycerol diglycidyl ether 39.2g (0.2mol), hexamethylene diamine
32.4g (0.28mol) was dissolved in 50ml of chloroform and added, and dioctyl phthalate was added as a pore opening agent.
A prepolymer solution is obtained by adding 20 g and reacting at a reaction temperature of 28° C. for 3 hours. Next, a solution of 10 g of triglycidyl isocyanurate dissolved in 30 ml of chloroform was added to this, and the reaction temperature was 28°C.
After reacting for 1 hour at °C, 40 g of sodium chloride,
Add 800 ml of an aqueous solution containing 6 g of bentonite and suspend and disperse at a stirring speed of 130 rpm.

次に反応枩床を50℃に䞊昇させお時間反応さ
せた埌、反応枩床を70℃たで埐々に䞊昇させお溶
媒のクロロホルムを留去させながら時間反応を
行぀た。反応終了埌、球圢重合䜓を分離し、曎に
メタノヌル抜出、掗浄、氎掗を行うこずにより吞
着剀80gを埗た。
Next, the reaction temperature was raised to 50°C and the reaction was carried out for 1 hour, and then the reaction temperature was gradually raised to 70°C and the reaction was carried out for 2 hours while distilling off the solvent chloroform. After the reaction was completed, the spherical polymer was separated and further extracted with methanol, washed, and washed with water to obtain 80 g of adsorbent.

この吞着剀をPH7.4のリン酞緩衝液䞭に浞挬凊
理した埌、mlを採取し、ビリルビン10mgdl、
むンドシアニングリヌンICGmgdl、ブロ
モスルホフタレむンBSPmgdlを含有す
る牛血枅20ml䞭に浞挬しお、37℃の枩床で時間
振盪した埌、吞着剀を分離しお、牛血枅䞭に残存
する各成分の濃床を枬定し、吞着率を求めたずこ
ろ、ビリルビン、ICG41、BSP48の各
吞着率が埗られ、血枅䞭の蛋癜結合性物質をよく
吞着しおいるこずが認められた。曎にこの吞着剀
20mlをシリコヌン凊理したガラス補カラムに充填
し、頚動静脈シダント手術を斜した玄3.0Kgの家
兎を甚いお20ml分の流速により血液䜓倖朅流を
時間行な぀た埌、返血しお吞着剀の状態を芳察
した結果、血栓等の圢成は党く認められず、血液
適合性は良奜であ぀た。
After immersing this adsorbent in a phosphate buffer solution with a pH of 7.4, 2 ml was collected, and bilirubin was 10 mg/dl.
After soaking in 20 ml of bovine serum containing 1 mg/dl of indocyanine green (ICG) and 5 mg/dl of bromosulfophthalein (BSP) and shaking at a temperature of 37°C for 3 hours, the adsorbent was separated. When we measured the concentration of each component remaining in bovine serum and determined the adsorption rate, we obtained adsorption rates of 50% for bilirubin, 41% for ICG, and 48% for BSP. It was recognized that there was. Furthermore, this adsorbent
20 ml was packed into a silicone-treated glass column, and extracorporeal blood perfusion was performed for 3 hours at a flow rate of 20 ml/min using an approximately 3.0 kg domestic rabbit that had undergone carotid arteriovenous shunt surgery, and then the blood was returned. As a result of observing the state of the adsorbent, no formation of thrombi or the like was observed, and blood compatibility was good.

比范䟋  吞着剀ずしおセルロヌル被芆掻性炭及びアンバ
ヌラむトXAD―ロヌム・アンド・ハヌス瀟
補を甚いお、実斜䟋ず同様の方法で、牛血枅
䞭のビリルビン、むンドシアニングリヌン
ICG、ブロモスルホフタレむンBSPの振盪
吞着詊隓を行぀た凊、セルロヌル被芆掻性炭は吞
着率はいずれもであり、アンバヌラむト
XAD―はビリルビン30、ICG35、BSP15
の各吞着率であ぀た。
Comparative Example 1 Bilirubin, indocyanine green (ICG), In a shaking adsorption test of bromosulfophthalein (BSP), cellulose-coated activated carbon had an adsorption rate of 0%, and Amberlite
XAD-7 is bilirubin 30%, ICG 35%, BSP15
% of each adsorption rate.

実斜䟋  実斜䟋ず同様の方法で、グリセロヌルゞグリ
シゞル゚ヌテルの代りに゚チレングリコヌルゞグ
リシゞル゚ヌテル34.8gを甚い、他は党お同様に
しお球状重合䜓粒子からなる吞着剀を補造した。
Example 2 An adsorbent made of spherical polymer particles was produced in the same manner as in Example 1, except that 34.8 g of ethylene glycol diglycidyl ether was used instead of glycerol diglycidyl ether, and all other conditions were the same.

この吞着剀mlを採取し、実斜䟋ず同様の方
法で、牛血枅䞭のビリルビン、むンドシアニング
リヌンICG、プロモスルホフタレむンBSP
の振盪吞着詊隓を行぀た凊、ビリルビン60、
ICG60、BSP65の各吞着率が埗られた。
Collect 2 ml of this adsorbent and use the same method as in Example 1 to detect bilirubin, indocyanine green (ICG), and promosulfophthalein (BSP) in bovine serum.
When a shaking adsorption test was conducted, bilirubin 60%,
Adsorption rates of ICG 60% and BSP 65% were obtained.

実斜䟋  実斜䟋ず同様の方法で、ビスプノヌル―
―ゞグリシゞル゚ヌテル19.0g、―ブタン
ゞオヌルゞグリシゞル゚ヌテル40.4g、4′―
ゞアミノゞプニルメタン27.6g及びヘキサメチ
レンゞアミン16.2gをクロロホルム40ml、シクロ
ヘキサン20ml及びゞオクチルフタレヌト20gの存
圚䞋に、28℃の枩床で反応させおプレポリマヌ溶
液を調補し、これを塩化ナトリりム40g、炭酞カ
ルシりム10gを含有する氎性媒䜓䞭に懞濁分散さ
せた埌、トリグリシゞルむ゜シアヌレヌト10g、
クロロホルム20ml及びシクロヘキサン10mlからな
る溶液を加えお50〜70℃の枩床で架橋硬化反応を
行い、球状重合䜓からなる吞着剀90gを埗た。
Example 3 In the same manner as in Example 1, bisphenol-A
-Diglycidyl ether 19.0g, 1,4-butanediol diglycidyl ether 40.4g, 4,4'-
A prepolymer solution was prepared by reacting 27.6 g of diaminodiphenylmethane and 16.2 g of hexamethylene diamine in the presence of 40 ml of chloroform, 20 ml of cyclohexane, and 20 g of dioctyl phthalate at a temperature of 28°C, and this was mixed with 40 g of sodium chloride and calcium carbonate. 10 g of triglycidyl isocyanurate after suspension dispersion in an aqueous medium containing 10 g of
A solution consisting of 20 ml of chloroform and 10 ml of cyclohexane was added, and a crosslinking and curing reaction was carried out at a temperature of 50 to 70°C to obtain 90 g of an adsorbent made of a spherical polymer.

この吞着剀mlを採取し、実斜䟋ず同様の方
法で、牛血枅䞭のビリルビン、むンドシアニング
リヌンICG、プロモスルホフタレむンBSP
の振盪吞着詊隓を行぀た凊、ビリルビン75、
ICG75、BSP81の各吞着率が埗られた。
Collect 2 ml of this adsorbent and use the same method as in Example 1 to detect bilirubin, indocyanine green (ICG), and promosulfophthalein (BSP) in bovine serum.
When a shaking adsorption test was conducted, bilirubin was 75%,
Adsorption rates of ICG 75% and BSP 81% were obtained.

実斜䟋  実斜䟋ず同様の方法で、ビスプノヌル―
―ゞグリシゞル゚ヌテル19.0g、゚チレングリコ
ヌルゞグリシゞル゚ヌテル34.8g、4′―ゞア
ミノゞプニルメタン27.6g及びヘキサメチレン
ゞアミン16.2gをクロロホルム40ml及びゞオクチ
ルフタレヌト20gの存圚䞋に、28℃の枩床で反応
させおプリポリマヌ溶液を調補し、これを塩化ナ
トリりム40g、ベントナむト6.0gを含有する氎性
媒䜓800ml䞭に150r.p.mの撹拌速床で撹拌しお懞
濁分散させた埌、トリグリシゞルむ゜シアヌレヌ
ト10g、クロロホルム30mlからなる溶液を加えお
50〜70℃の枩床で架橋硬化反応を行ない、球状重
合䜓からなる吞着剀85gを埗た。
Example 4 In the same manner as in Example 1, bisphenol-A
- Reaction of 19.0 g of diglycidyl ether, 34.8 g of ethylene glycol diglycidyl ether, 27.6 g of 4,4'-diaminodiphenylmethane and 16.2 g of hexamethylene diamine in the presence of 40 ml of chloroform and 20 g of dioctyl phthalate at a temperature of 28°C. A prepolymer solution was prepared, and this was suspended and dispersed in 800 ml of an aqueous medium containing 40 g of sodium chloride and 6.0 g of bentonite by stirring at a stirring speed of 150 rpm, followed by 10 g of triglycidyl isocyanurate and chloroform. Add a solution consisting of 30 ml
A crosslinking and curing reaction was carried out at a temperature of 50 to 70°C to obtain 85 g of an adsorbent made of a spherical polymer.

この吞着剀mlを甚いお、実斜䟋ず同様の方
法で牛血枅䞭のビリルビン、むンドシアニングリ
ヌンICG、プロモスルホフタレむンBSR
の振盪吞着詊隓を行぀た凊、ビリルビン65、
ICG62、BSP61の各吞着率が埗られた。曎に
頚動静脈シダント手術を斜した家兎を甚いた血液
䜓倖朅流詊隓によ぀お血液適合性が良奜なこずが
認められた。
Using 2 ml of this adsorbent, bilirubin, indocyanine green (ICG), and promosulfophthalein (BSR) in bovine serum were detected in the same manner as in Example 1.
When a shaking adsorption test was conducted, bilirubin was 65%,
Adsorption rates of ICG 62% and BSP 61% were obtained. Furthermore, good blood compatibility was confirmed in an extracorporeal blood perfusion test using rabbits that had undergone carotid artery shunt surgery.

実斜䟋  実斜䟋ず同様の方法で、トリグリシゞルむ゜
シアヌレヌト20g、゚チレングリコヌルゞグリシ
ゞル゚ヌテル34.8g、ヘキサメチレンゞアミン
31.0g及びステアリルアミン17.2gを、クロロホル
ム40ml及びパラフむン20gの存圚䞋に、28℃の枩
床で反応させおプレポリマヌ溶液を調補し、これ
を塩化ナトリりム40g、ベントナむト6.0gを含有
する氎性媒䜓800ml䞭に150r.p.mの撹拌速床で撹
拌しお懞濁分散させた埌、トリグリシゞルむ゜シ
アヌレヌト10g、クロロホルム30mlからなる溶液
を加えお50〜70℃の枩床で架橋反応を行い、球状
重合䜓からなる吞着剀100gを埗た。
Example 5 In the same manner as in Example 1, 20 g of triglycidyl isocyanurate, 34.8 g of ethylene glycol diglycidyl ether, and hexamethylene diamine were added.
A prepolymer solution was prepared by reacting 31.0 g of stearylamine and 17.2 g of stearylamine in the presence of 40 ml of chloroform and 20 g of paraffin at a temperature of 28° C., which was dissolved in 800 ml of an aqueous medium containing 40 g of sodium chloride and 6.0 g of bentonite. After suspension and dispersion by stirring at a stirring speed of 150 rpm, a solution consisting of 10 g of triglycidyl isocyanurate and 30 ml of chloroform is added, and a crosslinking reaction is carried out at a temperature of 50 to 70°C to form an adsorbent made of spherical polymers. 100g of the drug was obtained.

この吞着剀mlを甚いお、実斜䟋ず同様の方
法で、牛血枅䞭のビリルビン、むンドシアニング
リヌンICG、プロモスルホフタレむンBSP
の振盪吞着詊隓を行い、ビリルビン70、ICG68
、眉SP70の各吞着率が埗られた。本発明の
蛋癜結合性物質をよく吞着するこずが認められ
た。
Using 2 ml of this adsorbent, bilirubin, indocyanine green (ICG), and promosulfophthalein (BSP) in bovine serum were detected in the same manner as in Example 1.
A shaking adsorption test was conducted, and bilirubin 70%, ICG68
% and eyebrow SP70% were obtained. It was found that the protein-binding substance of the present invention was well adsorbed.

Claims (1)

【特蚱請求の範囲】[Claims]  倚䟡アミン化合物ず倚䟡゚ポキシ化合物ずを
氎ず䞍混和性の䞍掻性有機溶媒䞭においお30℃未
満の枩床で重付加反応せしめ、次いで必芁に応じ
お該倚䟡゚ポキシ化合物を远加するこずによ぀お
反応に䜿甚する該倚䟡゚ポキシ化合物䞭の党゚ポ
キシ基が反応に䜿甚する該倚䟡アミン化合物䞭の
アミン基及びむミノ基の圓量圓り又は該倚䟡ア
ミン化合物䞭にむミノ基を含たない堎合にはアミ
ノ基圓量圓り1.05〜1.70圓量の範囲ずなるよう
に調敎し、分散安定剀を含有する氎性媒䜓䞭に懞
濁分散せしめ、30℃以䞊の枩床で曎に反応を行う
こずにより懞濁粒子を架橋硬化せしめるこずから
なる吞着剀の補造方法。
1 Polyvalent amine compound and polyvalent epoxy compound are subjected to a polyaddition reaction in an inert organic solvent immiscible with water at a temperature of less than 30°C, and then the polyvalent epoxy compound is added as necessary. Therefore, all the epoxy groups in the polyvalent epoxy compound used in the reaction are per equivalent of the amine groups and imino groups in the polyvalent amine compound used in the reaction, or the polyvalent amine compound does not contain imino groups. In case, the amount is adjusted to be in the range of 1.05 to 1.70 equivalents per equivalent of amino group, suspended and dispersed in an aqueous medium containing a dispersion stabilizer, and further reacted at a temperature of 30°C or higher. A method for producing an adsorbent comprising crosslinking and curing particles.
JP56167047A 1981-10-21 1981-10-21 Preparation of adsorbent Granted JPS5869817A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56167047A JPS5869817A (en) 1981-10-21 1981-10-21 Preparation of adsorbent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56167047A JPS5869817A (en) 1981-10-21 1981-10-21 Preparation of adsorbent

Publications (2)

Publication Number Publication Date
JPS5869817A JPS5869817A (en) 1983-04-26
JPH0152027B2 true JPH0152027B2 (en) 1989-11-07

Family

ID=15842401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56167047A Granted JPS5869817A (en) 1981-10-21 1981-10-21 Preparation of adsorbent

Country Status (1)

Country Link
JP (1) JPS5869817A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3733658B2 (en) * 1995-12-28 2006-01-11 東レ株匏䌚瀟 β2 microglobulin removal, detection or measurement material and body fluid purification column using the same

Also Published As

Publication number Publication date
JPS5869817A (en) 1983-04-26

Similar Documents

Publication Publication Date Title
US6037458A (en) Adsorbent for serum amyloid protein
Guo et al. Hollow mesoporous carbon spheres—an excellent bilirubin adsorbent
JP2001508775A (en) Method and apparatus for reducing small organic compounds from blood products
JPS6259124B2 (en)
JP2003523777A (en) Batch device for the reduction of compounds from biological compositions containing cells and methods of use thereof
US7408045B2 (en) Adsorbent of high-mobility-group protein and body fluid-purification column
EP0028937B1 (en) Albumin-fixed resin, process for its production, method of using it to remove noxious substances from solutions containing them, and its use in removing noxious substances from blood
JPS6241667A (en) Adsorbing material for immunoglobrin and adsorbing apparatusequipped therewith
CN103933947B (en) For blood purification material removing rheumatoid factor and preparation method thereof
JPH0152027B2 (en)
SK36293A3 (en) Process for preparing optially active cyanohydrins with enzymes
JPS639450A (en) Body fluid component separating material and body fluid component separator equipped therewith
JPS6333872B2 (en)
JP6911681B2 (en) Method for purifying adsorbents and target substances
JP4228498B2 (en) Heparin adsorbent and method for removing heparin using the same
US6309999B1 (en) Process for the preparation of an immunoadsorbent matrix
RU2029564C1 (en) Adsorbent for extracting atherogenic lipoproteins from biological liquids
JPH0738881B2 (en) Container for removing activated complement components
JPH0616842B2 (en) Adsorbent for activated complement components
JPH05285381A (en) Low-specific gravity lipoprotein adsorptive material
CN121287934A (en) Covalent organic framework materials for loading boron drug compounds, their preparation methods and applications
JPH0753177B2 (en) Method for adsorption removal of β2-microglobulin
JPS62244442A (en) Low specific gravity lipoprotein adsorbing material and its preparation
JP3181343B2 (en) Method for producing adsorbent material for body fluid purification
JP2730211B2 (en) Adsorbent for anti-acetylcholine receptor antibody